788 related articles for article (PubMed ID: 21725561)
21. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
[TBL] [Abstract][Full Text] [Related]
22. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
23. Functionalized mesoporous silica nanoparticles: a possible strategy to target cancer cells reducing peripheral nervous system uptake.
Ceresa C; Nicolini G; Rigolio R; Bossi M; Pasqua L; Cavaletti G
Curr Med Chem; 2013; 20(20):2589-600. PubMed ID: 23627934
[TBL] [Abstract][Full Text] [Related]
24. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
Kim SH; Jeong JH; Chun KW; Park TG
Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
[TBL] [Abstract][Full Text] [Related]
25. Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release.
Zou Z; He X; He D; Wang K; Qing Z; Yang X; Wen L; Xiong J; Li L; Cai L
Biomaterials; 2015 Jul; 58():35-45. PubMed ID: 25941780
[TBL] [Abstract][Full Text] [Related]
26. Folate-PEG modified poly(2-(2-aminoethoxy)ethoxy)phosphazene/DNA nanoparticles for gene delivery: synthesis, preparation and in vitro transfection efficiency.
Zhang P; Zhang Z; Yang Y; Li Y
Int J Pharm; 2010 Jun; 392(1-2):241-8. PubMed ID: 20298769
[TBL] [Abstract][Full Text] [Related]
27. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
28. Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells.
Langston Suen WL; Chau Y
J Pharm Pharmacol; 2014 Apr; 66(4):564-73. PubMed ID: 24635558
[TBL] [Abstract][Full Text] [Related]
29. The packaging of siRNA within the mesoporous structure of silica nanoparticles.
Li X; Xie QR; Zhang J; Xia W; Gu H
Biomaterials; 2011 Dec; 32(35):9546-56. PubMed ID: 21906804
[TBL] [Abstract][Full Text] [Related]
30. Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding.
Wang LS; Wu LC; Lu SY; Chang LL; Teng IT; Yang CM; Ho JA
ACS Nano; 2010 Aug; 4(8):4371-9. PubMed ID: 20731423
[TBL] [Abstract][Full Text] [Related]
31. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
Rosenholm JM; Sahlgren C; Lindén M
Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
[TBL] [Abstract][Full Text] [Related]
32. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
[TBL] [Abstract][Full Text] [Related]
33. In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.
Garcia-Bennett A; Nees M; Fadeel B
Biochem Pharmacol; 2011 Apr; 81(8):976-84. PubMed ID: 21300030
[TBL] [Abstract][Full Text] [Related]
34. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
[TBL] [Abstract][Full Text] [Related]
35. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
[TBL] [Abstract][Full Text] [Related]
37. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional nanoparticles as nanocarrier for vincristine sulfate delivery to overcome tumor multidrug resistance.
Wang Y; Dou L; He H; Zhang Y; Shen Q
Mol Pharm; 2014 Mar; 11(3):885-94. PubMed ID: 24483832
[TBL] [Abstract][Full Text] [Related]
39. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
[TBL] [Abstract][Full Text] [Related]
40. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]